InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Explore the detailed record of transactions filed by Botwood Nicholas A.J.. Officer active across 2 companies, notably Syndax Pharmaceuticals Inc. In total, 6 reports have been recorded. Breakdown: 1 buy · 2 sells. Total volume traded: €95k. Activity tracked since 16 May 2025. The latest transaction was disclosed on 4 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Botwood Nicholas A.J. is a declarant linked to Syndax Pharmaceuticals Inc, where the listed role is Head of R&D, CMO. He has 6 filings in total, and in the recent filings tracked, the period runs from 2025-05-19 to 2026-06-12, with EUR 94549 of buys and EUR 0 of sells, and the most frequent transaction nature is Levée d'options.